SOLY - Soliton receives FDA acceptance for 510(k) application for its second generation Rapid Acoustic Pulse device for cellulite reduction (Stock Price: 7.64)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.